Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • morning latte
    Member
    • Jun 2013
    • 91

    #1

    What do you do with unused reads after de novo assembly?

    Dear all,

    I have metagenomic data which was produced from Illumina HiSeq 100 PE sequencing. After de novo assembly using velvet with a range of kmers, I came up with one kmer. When I looked at the percent of reads used for assembly, 70% of reads were actually used. I got curious what people are doing with the rest of 30% of unused reads and looked into threads related to this but haven't got a clear idea. Could anyone give me some advice or direct me any publication? Thanks!
  • Brian Bushnell
    Super Moderator
    • Jan 2014
    • 2709

    #2
    Regardless of which reads were used, you might try mapping all input reads to the assembly, then assembling the pile of reads that did not map with some score cutoff. It's difficult for assemblers to handle metagenomes with exponentially-distributed coverage and this makes it a lot easier to assemble the high-coverage organisms in one pass and the low-coverage organisms (if possible) in a second pass. Iterate as needed, as long as coverage is sufficient for assembly.

    Comment

    Latest Articles

    Collapse

    • SEQadmin2
      16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
      by SEQadmin2




      NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
      Today, 06:46 AM
    • SEQadmin2
      Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
      by SEQadmin2



      Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

      Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
      ...
      10-14-2026, 09:55 AM

    ad_right_rmr

    Collapse

    News

    Collapse

    Topics Statistics Last Post
    Started by SEQadmin2, 10-28-2026, 09:57 AM
    0 responses
    24 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-28-2026, 09:51 AM
    0 responses
    15 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 11:13 AM
    0 responses
    68 views
    0 reactions
    Last Post SEQadmin2  
    Started by SEQadmin2, 10-22-2026, 10:48 AM
    0 responses
    48 views
    0 reactions
    Last Post SEQadmin2  
    Working...